PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23086737-1	2013	The aims of this study were to assess the effects and potential mechanisms of parthenolide on the expression of vascular endothelial growth factor (VEGF), interleukin 8 (IL-8) and matrix metalloproteinase 9 (MMP-9) in human breast cancer cell line MDA-MB-231.	parthenolide	78-90	matrix metallopeptidase 9	Homo sapiens	180-206	
23086737-1	2013	The aims of this study were to assess the effects and potential mechanisms of parthenolide on the expression of vascular endothelial growth factor (VEGF), interleukin 8 (IL-8) and matrix metalloproteinase 9 (MMP-9) in human breast cancer cell line MDA-MB-231.	parthenolide	78-90	matrix metallopeptidase 9	Homo sapiens	208-213	
23086737-5	2013	The real-time PCR and Western blot data showed that the expressions of VEGF, IL-8 and MMP-9 were significantly inhibited by parthenolide at both transcription level and protein level in MDA-MB-231 cells.	parthenolide	124-136	matrix metallopeptidase 9	Homo sapiens	86-91	
23086737-8	2013	Hence, the expression of VEGF, IL-8 and MMP-9 may be suppressed by parthenolide through the inhibition of NF-kappaB DNA-binding activity in MDA-MB-231 cells.	parthenolide	67-79	matrix metallopeptidase 9	Homo sapiens	40-45